CTLA4 and neoplasm: This can be regarded as an “intrinsic vaccination.” Preclinical experiments with tumor bearing mice that have been treated with RT and CTLA-4 blocking agents revealed that CTLA-4 therapy on its own is not able to elicit a systemic effect in regard to tumor outgrowth of a second, non-irradiated tumor.